GSK seeks OTC status for nicotine oral spray in US

20 August 2019 - Deborah Wilkes

Premium

GlaxoSmithKline (GSK) Consumer Healthcare is seeking to extend its range of OTC nicotine-replacement therapy (NRT) products in the US with a nicotine oral spray.

Click tags below for more information on topics:

GlaxoSmithKline FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: